BCYC
Price
$24.58
Change
+$1.05 (+4.46%)
Updated
Oct 9 closing price
21 days until earnings call
SRRK
Price
$27.77
Change
-$1.72 (-5.83%)
Updated
Oct 9 closing price
32 days until earnings call
Ad is loading...

BCYC vs SRRK

Header iconBCYC vs SRRK Comparison
Open Charts BCYC vs SRRKBanner chart's image
Bicycle Therapeutics
Price$24.58
Change+$1.05 (+4.46%)
Volume$548.7K
CapitalizationN/A
Scholar Rock Holding
Price$27.77
Change-$1.72 (-5.83%)
Volume$6.62M
CapitalizationN/A
View a ticker or compare two or three
BCYC vs SRRK Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BCYC vs. SRRK commentary
Oct 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a StrongBuy and SRRK is a StrongSell.

COMPARISON
Comparison
Oct 10, 2024
Stock price -- (BCYC: $24.58 vs. SRRK: $27.77)
Brand notoriety: BCYC and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 115% vs. SRRK: 343%
Market capitalization -- BCYC: $1.6B vs. SRRK: $641.06M
BCYC [@Biotechnology] is valued at $1.6B. SRRK’s [@Biotechnology] market capitalization is $641.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 4 bearish.
  • SRRK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BCYC and SRRK are a good buy in the short-term.

Price Growth

BCYC (@Biotechnology) experienced а +8.95% price change this week, while SRRK (@Biotechnology) price change was +277.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 04, 2025.

SRRK is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($1.6B) has a higher market cap than SRRK($641M). SRRK YTD gains are higher at: 47.713 vs. BCYC (35.951). BCYC has higher annual earnings (EBITDA): -153.09M vs. SRRK (-207.14M). BCYC has more cash in the bank: 961M vs. SRRK (190M). BCYC has less debt than SRRK: BCYC (42.7M) vs SRRK (68M). BCYC has higher revenues than SRRK: BCYC (39.6M) vs SRRK (0).
BCYCSRRKBCYC / SRRK
Capitalization1.6B641M250%
EBITDA-153.09M-207.14M74%
Gain YTD35.95147.71375%
P/E RatioN/AN/A-
Revenue39.6M0-
Total Cash961M190M506%
Total Debt42.7M68M63%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCSRRK
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RLAY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+4.46%
RLAY - BCYC
44%
Loosely correlated
+2.56%
PHIO - BCYC
41%
Loosely correlated
+2.85%
XNCR - BCYC
40%
Loosely correlated
+1.13%
SRRK - BCYC
36%
Loosely correlated
-5.83%
ORMP - BCYC
35%
Loosely correlated
+3.00%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with RCUS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-5.83%
RCUS - SRRK
42%
Loosely correlated
+1.55%
ORMP - SRRK
42%
Loosely correlated
+3.00%
PLRX - SRRK
41%
Loosely correlated
+2.14%
VTGN - SRRK
40%
Loosely correlated
-0.68%
SNDX - SRRK
39%
Loosely correlated
-0.33%
More